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In Liberia, for virtually all model 
parameters, EVD deaths exceeded the 
expected number of deaths due to 
the leading non-EVD cause of death 
(ﬁ gure). In Sierra Leone, a broad range 
of model parameters also indicated 
that EVD might have killed more 
people in 2014 than the leading non-
EVD cause of death (ie, malaria). In 
other sets of model parameters, EVD 
still killed more people than the second 
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With more than 20 000 cases reported, 
the outbreak of Ebola virus disease 
(EVD) in west Africa is by far the largest 
in recorded history. Despite the scale 
of the current outbreak, EVD is often 
perceived as a “small-scale killer”.1 
By comparison, malaria caused an 
estimated 854 000 deaths world wide 
in 2013.2 However, although limited 
at the global level, the impact of EVD 
on mortality could be substantial in 
countries with intense transmission. 
We thus aimed to compare EVD with 
other causes of death in Liberia, Sierra 
Leone, and Guinea in 2014. 
We did an uncertainty analysis of 
EVD mortality (see appendix), based on 
two parameters: the extent of under-
reporting of EVD cases and the case 
fatality rate (CFR)—ie, the proportion 
of EVD cases who die. Similar to 
other analyses of EVD spread,3 we 
hypothesised that there were up to 
2·5 times more EVD cases than reported. 
This factor derives from a mathematical 
model, which compared the reported 
number of EVD cases to the number of 
beds in use in Ebola treatment units in 
August, 2014.4 We assumed that the 
CFR varied between 60% and 85%. The 
lower rate corresponds to CFRs seen 
among hospitalised EVD patients with 
known disease outcomes.5 Lower CFRs 
have been documented, but only in 
Ebola treatment units that implement 
non-standard treatment protocols.6 The 
upper rate corresponds to CFRs seen in 
non-hospitalised EVD patients.5
We estimated the number of EVD 
deaths as the product of (1) the 
reported number of EVD cases, (2) 
the under-reporting factor and (3) 
the CFR. Based solely on confirmed 
and probable EVD cases, the number 
of EVD deaths in 2014 ranged 
from 2928 to 10 372 in Liberia, 
from 4468 to 15 824 in Sierra Leone, 
and from 1739 to 5548 in Guinea.
We used the most recent (2013) 
national estimates of non-EVD 
mortality,2,7 together with projections 
of population growth, to calculate the 
expected number of deaths from non-
EVD causes in Liberia, Sierra Leone, and 
Guinea in 2014. For all com binations 
of model parameters, we mapped how 
the estimated number of EVD deaths 
ranked relative to the expected number 
of deaths from non-EVD causes.
Figure: Comparison of Ebola virus disease (EVD) deaths and expected deaths from non-EVD causes in 
Liberia, Sierra Leone, and Guinea in 2014
LRI=lower respiratory infections. White contours represent estimated number of EVD deaths in 2014 for 
speciﬁ c combinations of model parameters (where 2·5k = 2500 deaths, etc). Calculations of number of EVD 
deaths, and comparisons with other causes of death, are described in the appendix. Range of possible case 
fatality rates (CFRs) is narrower in Guinea than in the other two countries because a higher percentage of EVD 
deaths was recorded in that country among reported EVD cases. Lower bound of CFR is thus set at level 
estimated by surveillance data in that country. To aid ﬁ gure interpretation, we illustrate the case of Sierra 
Leone. In the red area, there are more EVD deaths than we expect deaths from the leading non-EVD cause of 
death in that country—ie, malaria. Hence, in this region of the parameter space, EVD would be the ﬁ rst cause 
of death. In the light blue area, there are fewer EVD deaths than deaths from the leading non-EVD cause of 
death, but there are more EVD deaths than deaths from the second non-EVD cause of death (ie, LRI). Hence 
EVD would be the second cause of death in that region of the parameter space. In the slightly darker blue area 
at the bottom of the graph, there are fewer EVD deaths than deaths from LRI, but more than deaths from HIV/
AIDS—ie, the third leading non-EVD cause of death (see appendix). EVD would thus be the third leading cause 
of death in that region of the parameter space. The boundary between the red and light blue areas (marked 
“malaria”) represents combinations of model parameters where the number of EVD deaths is equal to the 
expected number of malaria deaths. The boundary between the light blue and the darker blue areas (marked 
“LRI”) represents combinations for which the number of EVD deaths is equal to the expected number of LRI 
deaths. In Guinea, the entire graph is dark blue because the number of EVD deaths is lower than the expected 
number of deaths from the third non-EVD cause of death in the country for all model parameters.
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increased coordination between 
national and external actors to ensure 
that important components of the 
disease burden do not go unaddressed. 
Focusing on building high-quality 
health systems, capable of addressing a 
broad range of diseases including EVD, 
could help overcome this tension.14
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(ie, lower respiratory infect ions) or the 
third (ie, HIV/AIDS) leading causes of 
death. In Guinea, EVD never ranked 
higher than the top three non-EVD 
causes of death (ﬁ gure). The highest 
estimate of EVD deaths was slightly 
lower than the expected number of 
deaths from diarrhoeal diseases—ie, 
the fifth leading non-EVD cause of 
death in that country (see appendix). 
Our analyses have limitations. First, 
we do not account for increases in 
non-EVD deaths due to lower health-
care use during the outbreak.8 Second, 
the estimates of non-EVD mortality 
are based largely on imprecise survey 
or census data.2 Despite statistical 
corrections,9 they might under estimate 
the number of non-EVD deaths.10 Third, 
the range of model parameters we 
considered might be too broad. In one 
study of EVD viral sequences collected 
in June, 2014, in Sierra Leone, there 
were only up to 1·7 times more cases 
than reported.11 Case reporting might 
also have improved in the autumn of 
2014, as new Ebola treatment units 
were opened. Fourth, we only include 
confirmed and probable EVD cases, 
whereas EVD deaths might also be 
common among suspected cases (ie, 
cases without laboratory or clinical 
data).
Nonetheless, our analyses identify 
a large discrepancy between the high 
impact of EVD on mortality in Liberia 
and Sierra Leone (and to a lesser 
extent Guinea), and its low impact on 
mortality at global or continental levels. 
Since assessments of the burden of 
disease should inform the allocation of 
health investments,12 this discrepancy 
could create con flicting priorities 
among actors of the health sector 
in these countries. External actors 
operating across multiple countries and 
regions (eg, donors, non-governmental 
organis ations) might emphasise 
tackling diseases more common 
throughout sub-Saharan Africa than 
EVD.13 National governments, on the 
other hand, might stress the need to 
prevent future EVD outbreaks. The 
emergence of EVD will thus require 
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